COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES

摘要

RG-Cysteic Acid (ie, RG-NH-CH(CH ₂ -SO ₃ H)COOH or Arg-Gly-NH-CH(CH ₂ -SO ₃ H)COOH], and pharmaceuticals thereof As acceptable salts, hydrates, stereoisomers, multimers, cyclic forms, linear forms, drug-conjugates, Compounds comprising derivatives thereof, including pro-drugs and derivatives thereof. The preparation of such compounds, including inhibition of cellular adhesion to RGD binding sites in human or animal subjects, and other diagnostic or therapeutic delivery methods for RGD binding sites, and Methods for use are also shown.